Brief: Nykode Therapeutics Q4 Operating Loss At $8.1 Million
Feb 25 (Reuters) - Nykode Therapeutics ASA NYKD.OL: Q4 OPERATING LOSS USD 8,090 THOUSAND Q4 NET LOSS USD 7,997 THOUSAND Q4 TOTAL OPERATING EXPENSES USD 8,090 THOUSAND Source text: ID:nObiynr4Pa Further company coverage: NYKD.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026